Advertisement Banner
  • Home
  • News
  • Medicine
  • Health Tech
  • Health Living
  • Contact
  • Privacy Policy
No Result
View All Result
  • Home
  • News
  • Medicine
  • Health Tech
  • Health Living
  • Contact
  • Privacy Policy
No Result
View All Result
HealthNews
No Result
View All Result
Home Medicine

Mesh Bio, MultiOmic Health to generate AI-driven insights on Asian metabolic diseases

admin by admin
June 30, 2022
in Medicine



Singaporean health tech startup Mesh Bio and UK-based drug discovery firm MultiOmic Health have started collaborating to build a huge multi-omics dataset that will provide insights into metabolic syndrome-related conditions among Asians.

WHAT IT’S ABOUT

According to a press statement, Mesh Bio will tap on its network of healthcare providers to recruit participants for their study, specifically patients with chronic metabolic disease and increased risk of complications, such as chronic kidney disease. 

On its part, MultiOmic will generate genomic, proteomic, metabolomic and other omics data from anonymised body fluid samples. These omics data will then be combined with anonymised data from clinical and diagnostic tests to build a rich multi-omics dataset and to acquire AI-based computational biology models.

The organisations will also conduct joint projects to enhance patient stratification for the clinical stage R&D programmes of other biopharmaceutical and medical technology companies.

WHY IT MATTERS

The large multi-omics dataset they are building will enable the companies to advance their respective R&D programmes to develop precision therapeutic and diagnostic products for patients with metabolic syndrome-related conditions. 

“Longitudinal multi-omics data combined with deep clinical phenotyping is essential to developing transformative therapeutics and diagnostics in chronic multi-factorial diseases,” said Angeli Möller, vice-chairperson and co-founder of the global advocacy group Alliance for Artificial Intelligence in Healthcare.

Möller also said that the study will help generate “new and much-needed insights specific to populations in Asia,” who have been underrepresented in historical research on metabolic diseases.

Before the pandemic, metabolic diseases, which among others include type 2 diabetes mellitus and chronic kidney disease, accounted for half of the world’s death and nearly $2 trillion in global healthcare spending, based on estimates by MultiOmic. 

During the pandemic, patients with metabolic syndrome condition form a “significant” portion of COVID-19-related hospitalisations and deaths, according to a study published in the medical journal Diabetes Care. Recent studies have also indicated that COVID-19 survivors have shown an increased risk of getting type 2 diabetes and chronic kidney disease.

THE LARGER TREND

The Singapore-based gut microbiome company AMILI is another organisation that aims to fill the gap in gut health research that is representative of the Asian population. The company is building a large, multi-ethnic repository of microbiome data and samples from Asia that will assist academic institutions and biotech firms in identifying new biomarkers for the formulation of gut health products. Early this month, AMILI raised $10.5 million in Series A funding which will support its further expansion across Asia.

In other news, metabolic health-focused fitness app HealthifyMe recently came up with a new offering that combines health tracking and smart diagnostics. HealthifyPro is a fitness plan that comes with a biosensor system, including continuous glucose monitor; a connected Smart Scale metabolic panel; and support from in-house fitness coaches and AI assistant, Ria.



Source link

Advertisement Banner
Previous Post

Get Mental Health Help in Your Rural Area

Next Post

HHS Expands Access to Jynneos Vaccine in Light of Monkeypox Outbreak

Next Post

HHS Expands Access to Jynneos Vaccine in Light of Monkeypox Outbreak

Discussion about this post

Recommended

Hospital for Special Surgery claims top ranking for orthopedic care in the US

2 weeks ago

U.S. Issues New Warnings On ‘Forever Chemicals’ In Drinking Water

2 months ago

Don't Miss

Celebrating Health for 25 Years

August 8, 2022

Cherry Tomato Salad | Mark’s Daily Apple

August 8, 2022

Digital gastrointestinal care startup Salvo Health launches with $10.5M

August 8, 2022

Natural Language Processing and Digital Health Transformation, Health News, ET HealthWorld

August 8, 2022

© 2022 Pharma News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy.

Navigate Site

  • News
  • Medicine
  • Health Tech
  • Health Tech
  • Health Living
  • Contact
  • Privacy Policy

Newsletter Sign Up.

No Result
View All Result
  • Home
  • News
  • Medicine
  • Health Tech
  • Health Living
  • Contact
  • Privacy Policy

© 2022 JNews - Premium WordPress news & magazine theme by Jegtheme.